Not sure what strong means, and definitely not sure I trust any stats coming from the Bidementia administration. Supposedly in the third quarter real (after inflation) gross domestic product grew by 5.2%. (BEA Release) (I strongly encourage you to click on the link in the release that leads to the BEA sources for the data, it gives you a good sense of where likely error comes from.) That would be good growth. Whether it reflects reality is a different question. As usual, a closer look raises questions. One thing that is very apparent is that run-amok government spending is one of the primary drivers, as it’s contribution to economic growth is at the highest level in years. This spending is fueled by debt, and the negative impacts of that debt and accompanying high interest rates are just starting to impact the economy and consumers. Consumer spending increases were the primary source of the growth and we know from other data that consumers are stretched, in debt and unable to afford the increased costs of necessities. Zero Hedge gives its usual appropriately jaundiced view of the data here. (ZH Post)
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Cano Health apparently cannot, as it declares bankruptcy due to too much debt. Building primary care centers to serve Medicare, Medicaid and commercial populations, which is Cano’s business, was hot...
February 6, 2024
Turquoise health raises a fresh $30 million in capital for its price transparency platform, as the market for funding health care companies isn’t quite dead yet.
January 24, 2024
I am co-f0under of a company that manages cell and gene therapy for health plans. Cell therapy has made a big difference for many cancer patients but like all new...
January 24, 2024
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace